Zurcher Kantonalbank Zurich Cantonalbank Purchases 2,556 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 150,533 shares of the medical equipment provider's stock after acquiring an additional 2,556 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Intuitive Surgical were worth $73,952,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of ISRG. Ridgewood Investments LLC purchased a new position in Intuitive Surgical in the second quarter worth about $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. LRI Investments LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter worth approximately $30,000. LGT Financial Advisors LLC increased its position in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter worth $33,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $538.55 on Thursday. The firm has a 50-day simple moving average of $507.94 and a two-hundred day simple moving average of $466.79. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $552.00. The firm has a market cap of $191.82 billion, a price-to-earnings ratio of 86.58, a PEG ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on ISRG shares. Redburn Atlantic upgraded shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Oppenheimer reissued a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Royal Bank of Canada increased their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. Finally, Leerink Partners upped their price objective on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $526.06.

Insider Buying and Selling

In other news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the company's stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares in the company, valued at approximately $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,459 shares of company stock worth $26,080,251 in the last ninety days. 0.80% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.